Alexandra E. Shields, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spirituality | 14 | 2024 | 425 | 6.670 |
Why?
|
| Religion | 12 | 2023 | 372 | 3.220 |
Why?
|
| Adaptation, Psychological | 9 | 2024 | 2629 | 1.410 |
Why?
|
| Epigenomics | 3 | 2021 | 943 | 1.370 |
Why?
|
| Physicians, Family | 6 | 2008 | 350 | 1.310 |
Why?
|
| Tobacco Use Disorder | 10 | 2011 | 703 | 1.230 |
Why?
|
| Research Personnel | 3 | 2021 | 588 | 1.170 |
Why?
|
| Stress, Psychological | 10 | 2023 | 4481 | 1.030 |
Why?
|
| DNA Methylation | 6 | 2021 | 4399 | 1.020 |
Why?
|
| Telomere | 3 | 2020 | 943 | 0.910 |
Why?
|
| Leukocytes | 4 | 2020 | 2026 | 0.880 |
Why?
|
| Epigenesis, Genetic | 5 | 2021 | 3801 | 0.860 |
Why?
|
| Health Status Disparities | 7 | 2017 | 1853 | 0.780 |
Why?
|
| Smoking Cessation | 9 | 2011 | 2057 | 0.750 |
Why?
|
| Religion and Psychology | 2 | 2024 | 180 | 0.740 |
Why?
|
| Anthropology, Cultural | 1 | 2021 | 102 | 0.720 |
Why?
|
| Pharmacogenetics | 5 | 2011 | 675 | 0.710 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2021 | 701 | 0.700 |
Why?
|
| Genetic Research | 5 | 2017 | 171 | 0.690 |
Why?
|
| Genetic Testing | 6 | 2011 | 3537 | 0.650 |
Why?
|
| Medicaid | 8 | 2009 | 2818 | 0.620 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2016 | 305 | 0.590 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2019 | 224 | 0.590 |
Why?
|
| Smoking | 12 | 2016 | 9053 | 0.590 |
Why?
|
| Epidemiologic Research Design | 1 | 2020 | 368 | 0.550 |
Why?
|
| Hypertension | 4 | 2024 | 8540 | 0.550 |
Why?
|
| Palliative Care | 4 | 2021 | 3598 | 0.550 |
Why?
|
| Child Health Services | 3 | 2008 | 646 | 0.530 |
Why?
|
| Religion and Medicine | 1 | 2017 | 161 | 0.500 |
Why?
|
| BRCA2 Protein | 2 | 2011 | 805 | 0.490 |
Why?
|
| Mental Health | 2 | 2019 | 3250 | 0.490 |
Why?
|
| Medical Records Systems, Computerized | 7 | 2009 | 1192 | 0.450 |
Why?
|
| Health Status | 4 | 2020 | 4077 | 0.450 |
Why?
|
| BRCA1 Protein | 2 | 2011 | 1158 | 0.430 |
Why?
|
| Primary Health Care | 8 | 2011 | 4687 | 0.430 |
Why?
|
| Anxiety | 3 | 2023 | 4573 | 0.430 |
Why?
|
| United States | 34 | 2024 | 72340 | 0.400 |
Why?
|
| Social Environment | 1 | 2017 | 1020 | 0.390 |
Why?
|
| Community Health Centers | 2 | 2007 | 461 | 0.380 |
Why?
|
| Quality Assurance, Health Care | 2 | 2020 | 2169 | 0.370 |
Why?
|
| Cohort Studies | 8 | 2024 | 41495 | 0.370 |
Why?
|
| Jamaica | 2 | 2021 | 54 | 0.370 |
Why?
|
| Psychometrics | 1 | 2020 | 3065 | 0.350 |
Why?
|
| Ambulatory Care Information Systems | 2 | 2007 | 88 | 0.350 |
Why?
|
| Attitude of Health Personnel | 6 | 2011 | 3889 | 0.340 |
Why?
|
| Humans | 80 | 2024 | 761596 | 0.330 |
Why?
|
| Hospitals, Military | 1 | 2009 | 62 | 0.330 |
Why?
|
| Stress, Physiological | 1 | 2017 | 1403 | 0.330 |
Why?
|
| Caribbean Region | 2 | 2020 | 191 | 0.330 |
Why?
|
| Diffusion of Innovation | 5 | 2009 | 728 | 0.300 |
Why?
|
| Aid to Families with Dependent Children | 1 | 2007 | 23 | 0.300 |
Why?
|
| Social Support | 2 | 2016 | 2172 | 0.300 |
Why?
|
| Child Abuse | 1 | 2016 | 1077 | 0.290 |
Why?
|
| Genetic Counseling | 2 | 2008 | 627 | 0.290 |
Why?
|
| Pituitary-Adrenal System | 3 | 2021 | 552 | 0.290 |
Why?
|
| Biomedical Research | 3 | 2020 | 3429 | 0.280 |
Why?
|
| Health Benefit Plans, Employee | 2 | 2009 | 333 | 0.280 |
Why?
|
| Health Services Accessibility | 5 | 2009 | 5440 | 0.280 |
Why?
|
| Female | 41 | 2024 | 392705 | 0.270 |
Why?
|
| Asthma | 5 | 2008 | 6234 | 0.270 |
Why?
|
| Health Personnel | 1 | 2020 | 3335 | 0.270 |
Why?
|
| Obesity | 3 | 2023 | 12947 | 0.260 |
Why?
|
| Insurance, Health | 3 | 2008 | 2499 | 0.260 |
Why?
|
| Genes, BRCA2 | 1 | 2009 | 601 | 0.260 |
Why?
|
| Nicotine | 2 | 2010 | 680 | 0.260 |
Why?
|
| Mortality | 1 | 2017 | 2902 | 0.250 |
Why?
|
| Health Care Surveys | 5 | 2010 | 2426 | 0.250 |
Why?
|
| Professional Practice | 1 | 2007 | 313 | 0.250 |
Why?
|
| Behavior, Addictive | 1 | 2011 | 462 | 0.250 |
Why?
|
| Genes, BRCA1 | 1 | 2009 | 764 | 0.250 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2009 | 928 | 0.250 |
Why?
|
| Vulnerable Populations | 2 | 2008 | 703 | 0.250 |
Why?
|
| Interviews as Topic | 4 | 2020 | 2696 | 0.240 |
Why?
|
| Middle Aged | 25 | 2024 | 220921 | 0.240 |
Why?
|
| Adult | 25 | 2024 | 221210 | 0.240 |
Why?
|
| Private Sector | 1 | 2008 | 398 | 0.240 |
Why?
|
| Physicians | 2 | 2021 | 4591 | 0.230 |
Why?
|
| Depression | 1 | 2024 | 8126 | 0.230 |
Why?
|
| Neoplasms | 4 | 2020 | 22173 | 0.230 |
Why?
|
| Qualitative Research | 4 | 2020 | 3025 | 0.220 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 2518 | 0.220 |
Why?
|
| Chronic Disease | 5 | 2013 | 9319 | 0.220 |
Why?
|
| Health Maintenance Organizations | 2 | 2003 | 659 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2011 | 17904 | 0.220 |
Why?
|
| Healthcare Disparities | 3 | 2019 | 3358 | 0.210 |
Why?
|
| Acculturation | 1 | 2024 | 178 | 0.210 |
Why?
|
| Substance-Related Disorders | 2 | 2011 | 4420 | 0.210 |
Why?
|
| Physician's Role | 2 | 2007 | 917 | 0.210 |
Why?
|
| Socioeconomic Factors | 7 | 2020 | 7828 | 0.200 |
Why?
|
| Genetics, Behavioral | 1 | 2002 | 53 | 0.200 |
Why?
|
| Quality of Health Care | 5 | 2010 | 4331 | 0.200 |
Why?
|
| Breast Neoplasms | 4 | 2016 | 21019 | 0.200 |
Why?
|
| Behavioral Research | 1 | 2002 | 52 | 0.190 |
Why?
|
| Patient Care | 1 | 2007 | 622 | 0.190 |
Why?
|
| Prospective Studies | 6 | 2021 | 54423 | 0.190 |
Why?
|
| Women's Health | 3 | 2021 | 2065 | 0.190 |
Why?
|
| Geriatric Assessment | 1 | 2009 | 1410 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2024 | 12149 | 0.190 |
Why?
|
| Prejudice | 4 | 2019 | 570 | 0.190 |
Why?
|
| Molecular Biology | 1 | 2005 | 576 | 0.180 |
Why?
|
| Minority Groups | 3 | 2020 | 1203 | 0.180 |
Why?
|
| Hair | 2 | 2014 | 498 | 0.180 |
Why?
|
| Aged | 16 | 2024 | 169310 | 0.180 |
Why?
|
| Asia, Western | 1 | 2020 | 18 | 0.180 |
Why?
|
| Ethics, Medical | 1 | 2004 | 783 | 0.160 |
Why?
|
| Delivery of Health Care | 3 | 2020 | 5337 | 0.160 |
Why?
|
| Latin America | 1 | 2020 | 410 | 0.160 |
Why?
|
| Islam | 1 | 2019 | 70 | 0.160 |
Why?
|
| Health Behavior | 3 | 2017 | 2644 | 0.160 |
Why?
|
| Male | 27 | 2024 | 360846 | 0.150 |
Why?
|
| Quality of Life | 1 | 2019 | 13367 | 0.150 |
Why?
|
| Academies and Institutes | 1 | 2020 | 318 | 0.150 |
Why?
|
| Mental Healing | 1 | 2017 | 28 | 0.140 |
Why?
|
| Self-Assessment | 1 | 2019 | 397 | 0.140 |
Why?
|
| Genetic Privacy | 2 | 2011 | 59 | 0.140 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2016 | 29 | 0.140 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2020 | 793 | 0.140 |
Why?
|
| Genomics | 1 | 2012 | 5821 | 0.130 |
Why?
|
| Hydrocortisone | 2 | 2014 | 1819 | 0.130 |
Why?
|
| Environmental Exposure | 1 | 2011 | 4485 | 0.130 |
Why?
|
| Hospital Administration | 2 | 2010 | 353 | 0.130 |
Why?
|
| Adolescent | 12 | 2020 | 88326 | 0.130 |
Why?
|
| Blood Proteins | 1 | 2021 | 1173 | 0.130 |
Why?
|
| Clinical Competence | 2 | 2008 | 4793 | 0.130 |
Why?
|
| Clergy | 1 | 2015 | 79 | 0.120 |
Why?
|
| Health Surveys | 2 | 2018 | 4061 | 0.120 |
Why?
|
| Risk Factors | 9 | 2024 | 74213 | 0.110 |
Why?
|
| Allostasis | 1 | 2014 | 72 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 11904 | 0.110 |
Why?
|
| Risk | 2 | 2018 | 9610 | 0.100 |
Why?
|
| Ovarian Neoplasms | 1 | 2009 | 4878 | 0.100 |
Why?
|
| Medically Uninsured | 2 | 2008 | 836 | 0.100 |
Why?
|
| Sociology, Medical | 1 | 2012 | 62 | 0.100 |
Why?
|
| Child | 8 | 2020 | 80158 | 0.100 |
Why?
|
| Environment | 2 | 2016 | 1123 | 0.100 |
Why?
|
| Genes, erbB-2 | 1 | 2012 | 162 | 0.100 |
Why?
|
| Patient Participation | 1 | 2020 | 1445 | 0.090 |
Why?
|
| Alabama | 1 | 2011 | 108 | 0.090 |
Why?
|
| Incidence | 3 | 2021 | 21355 | 0.090 |
Why?
|
| Child, Preschool | 6 | 2016 | 42232 | 0.090 |
Why?
|
| Body Weight | 1 | 2021 | 4618 | 0.090 |
Why?
|
| Maryland | 1 | 2011 | 277 | 0.090 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 683 | 0.090 |
Why?
|
| Selection Bias | 1 | 2012 | 359 | 0.090 |
Why?
|
| Health Education | 1 | 2017 | 1052 | 0.090 |
Why?
|
| Confidentiality | 2 | 2004 | 609 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2016 | 1567 | 0.080 |
Why?
|
| Counseling | 2 | 2007 | 1547 | 0.080 |
Why?
|
| Women | 1 | 2011 | 223 | 0.080 |
Why?
|
| Research | 3 | 2007 | 1982 | 0.080 |
Why?
|
| Self Report | 1 | 2020 | 3725 | 0.080 |
Why?
|
| Anxiety Disorders | 1 | 2019 | 2720 | 0.080 |
Why?
|
| Patient Selection | 1 | 2020 | 4244 | 0.080 |
Why?
|
| Genetic Services | 1 | 2007 | 13 | 0.080 |
Why?
|
| Hospital Information Systems | 2 | 2009 | 394 | 0.070 |
Why?
|
| Uncompensated Care | 1 | 2008 | 37 | 0.070 |
Why?
|
| Emotions | 1 | 2020 | 2739 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2016 | 2767 | 0.070 |
Why?
|
| Genetic Heterogeneity | 1 | 2011 | 732 | 0.070 |
Why?
|
| Developing Countries | 1 | 2020 | 2885 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 1 | 2018 | 4740 | 0.070 |
Why?
|
| Medical Oncology | 1 | 2019 | 2321 | 0.070 |
Why?
|
| Capital Financing | 1 | 2007 | 58 | 0.070 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 2007 | 88 | 0.070 |
Why?
|
| Social Conditions | 2 | 2004 | 120 | 0.070 |
Why?
|
| Designer Drugs | 1 | 2007 | 21 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 58984 | 0.070 |
Why?
|
| Informed Consent | 2 | 2004 | 1008 | 0.070 |
Why?
|
| Education, Continuing | 1 | 2007 | 114 | 0.070 |
Why?
|
| Massachusetts | 3 | 2004 | 8833 | 0.060 |
Why?
|
| Medically Underserved Area | 1 | 2008 | 254 | 0.060 |
Why?
|
| Group Practice | 2 | 2008 | 151 | 0.060 |
Why?
|
| Cardiovascular Diseases | 3 | 2024 | 15502 | 0.060 |
Why?
|
| Pregnancy Outcome | 1 | 2016 | 2922 | 0.060 |
Why?
|
| Mental Disorders | 2 | 2017 | 6845 | 0.060 |
Why?
|
| Genetic Techniques | 1 | 2008 | 428 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2009 | 23996 | 0.060 |
Why?
|
| Health Policy | 2 | 2008 | 2684 | 0.060 |
Why?
|
| Cost Control | 1 | 2007 | 628 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 5790 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 20100 | 0.060 |
Why?
|
| Pregnancy | 2 | 2017 | 29890 | 0.060 |
Why?
|
| Databases, Genetic | 1 | 2011 | 1742 | 0.060 |
Why?
|
| Young Adult | 5 | 2016 | 59260 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2009 | 4016 | 0.060 |
Why?
|
| Terminal Care | 1 | 2015 | 1761 | 0.060 |
Why?
|
| Public Health | 1 | 2017 | 2669 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2009 | 2927 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2018 | 6567 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 3808 | 0.050 |
Why?
|
| Comorbidity | 2 | 2007 | 10508 | 0.050 |
Why?
|
| Life Style | 1 | 2014 | 3917 | 0.050 |
Why?
|
| Persuasive Communication | 1 | 2003 | 58 | 0.050 |
Why?
|
| Interdisciplinary Communication | 1 | 2008 | 931 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7391 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 2947 | 0.050 |
Why?
|
| Cultural Characteristics | 1 | 2003 | 251 | 0.050 |
Why?
|
| Family Practice | 1 | 2005 | 512 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 26129 | 0.050 |
Why?
|
| Attitude to Health | 1 | 2011 | 2025 | 0.050 |
Why?
|
| Tobacco Industry | 1 | 2003 | 136 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2021 | 80647 | 0.050 |
Why?
|
| Medical Order Entry Systems | 1 | 2006 | 521 | 0.050 |
Why?
|
| Private Practice | 1 | 2002 | 153 | 0.050 |
Why?
|
| Behavior | 1 | 2004 | 541 | 0.050 |
Why?
|
| Logistic Models | 3 | 2021 | 13255 | 0.040 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2002 | 395 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2004 | 1062 | 0.040 |
Why?
|
| Hospitals | 2 | 2010 | 3883 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2011 | 3188 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2011 | 10090 | 0.040 |
Why?
|
| Emigrants and Immigrants | 1 | 2024 | 543 | 0.040 |
Why?
|
| Poverty | 1 | 2009 | 2697 | 0.040 |
Why?
|
| Internal Medicine | 1 | 2005 | 1051 | 0.040 |
Why?
|
| Interprofessional Relations | 1 | 2003 | 990 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2008 | 2775 | 0.040 |
Why?
|
| Fee-for-Service Plans | 1 | 2002 | 700 | 0.030 |
Why?
|
| Disease Management | 1 | 2007 | 2508 | 0.030 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 1994 | 2199 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 12463 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2016 | 26202 | 0.030 |
Why?
|
| Epidemiologic Studies | 2 | 2013 | 675 | 0.030 |
Why?
|
| Genotype | 3 | 2005 | 12990 | 0.030 |
Why?
|
| Culture | 1 | 2019 | 623 | 0.030 |
Why?
|
| Alleles | 1 | 2007 | 6864 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2008 | 3600 | 0.030 |
Why?
|
| Prevalence | 2 | 2019 | 15733 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2007 | 3242 | 0.030 |
Why?
|
| Infant | 1 | 2016 | 36193 | 0.030 |
Why?
|
| Adolescent Behavior | 1 | 2003 | 1190 | 0.030 |
Why?
|
| CpG Islands | 1 | 2018 | 1230 | 0.030 |
Why?
|
| Veterans | 1 | 2007 | 2649 | 0.030 |
Why?
|
| Terminally Ill | 1 | 2015 | 240 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2010 | 4811 | 0.030 |
Why?
|
| Mass Screening | 1 | 2008 | 5429 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 8002 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2014 | 983 | 0.020 |
Why?
|
| Time Factors | 2 | 2010 | 39969 | 0.020 |
Why?
|
| American Recovery and Reinvestment Act | 1 | 2010 | 72 | 0.020 |
Why?
|
| Focus Groups | 1 | 2015 | 1415 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2019 | 2095 | 0.020 |
Why?
|
| Hospitalization | 2 | 2003 | 10721 | 0.020 |
Why?
|
| Saliva | 1 | 2013 | 828 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2014 | 1188 | 0.020 |
Why?
|
| Age Distribution | 1 | 2014 | 2879 | 0.020 |
Why?
|
| Physical Examination | 1 | 2014 | 1255 | 0.020 |
Why?
|
| Hospital Bed Capacity | 1 | 2009 | 206 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2010 | 713 | 0.020 |
Why?
|
| Proteomics | 1 | 2021 | 3848 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2014 | 1733 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2024 | 12953 | 0.020 |
Why?
|
| Practice Management, Medical | 1 | 2008 | 191 | 0.020 |
Why?
|
| Ownership | 1 | 2009 | 339 | 0.020 |
Why?
|
| Risk Adjustment | 1 | 2010 | 600 | 0.020 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2014 | 975 | 0.020 |
Why?
|
| Michigan | 1 | 2006 | 339 | 0.020 |
Why?
|
| Efficiency, Organizational | 1 | 2010 | 695 | 0.020 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2014 | 1081 | 0.010 |
Why?
|
| DNA | 1 | 2018 | 7213 | 0.010 |
Why?
|
| Hospital Costs | 1 | 2010 | 947 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2015 | 3575 | 0.010 |
Why?
|
| Organizational Innovation | 1 | 2006 | 537 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2021 | 11530 | 0.010 |
Why?
|
| Bupropion | 1 | 2005 | 304 | 0.010 |
Why?
|
| Virginia | 1 | 2003 | 116 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2021 | 22176 | 0.010 |
Why?
|
| Population Surveillance | 1 | 1992 | 2598 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 3415 | 0.010 |
Why?
|
| Boston | 1 | 2014 | 9327 | 0.010 |
Why?
|
| Personality Inventory | 1 | 2003 | 1019 | 0.010 |
Why?
|
| Longitudinal Studies | 2 | 2008 | 14608 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2007 | 1937 | 0.010 |
Why?
|
| Peer Group | 1 | 2003 | 692 | 0.010 |
Why?
|
| Risk-Taking | 1 | 2003 | 1038 | 0.010 |
Why?
|
| Length of Stay | 1 | 2010 | 6426 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2010 | 5293 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2010 | 3271 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2010 | 12341 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 12059 | 0.010 |
Why?
|
| Students | 1 | 2003 | 1741 | 0.010 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1993 | 662 | 0.010 |
Why?
|
| Employment | 1 | 1994 | 1118 | 0.000 |
Why?
|
| Algorithms | 1 | 2008 | 14033 | 0.000 |
Why?
|
| HIV Infections | 1 | 1993 | 17354 | 0.000 |
Why?
|
| Income | 1 | 1994 | 1877 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 1993 | 14665 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1993 | 15266 | 0.000 |
Why?
|
| Medicare | 1 | 1994 | 6770 | 0.000 |
Why?
|